We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Actelion Pharmaceuticals UK Ltd

Chiswick Tower 13th Floor, 389 Chiswick High Road, London, W4 4AL, UK
Telephone: +44 (0)208 987 3333
Fax: +44 (0)208 987 3322
WWW: http://www.actelion.com
Medical Information Direct Line: +44 (0)208 987 3333
Medical Information e-mail: medinfo_uk@actelion.com
Patient Information Leaflet last updated on medicines.ie: 29/11/2017
PIL Uptravi

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 29/11/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 6 - date of revision
Updated on 12/10/2017 and displayed until 29/11/2017
Reasons for adding or updating:
  • Change to section 6 - date of revision
Updated on 10/07/2017 and displayed until 12/10/2017
Reasons for adding or updating:
  • Change to section 2 - what you need to know - contraindications
Updated on 21/02/2017 and displayed until 10/07/2017
Reasons for adding or updating:
  • Change to section 6 - marketing authorisation number
  • Change to section 6 - date of revision
Updated on 10/10/2016 and displayed until 21/02/2017
Reasons for adding or updating:
  • Change of manufacturer
  • Change to warnings or special precautions for use
Updated on 19/05/2016 and displayed until 10/10/2016
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   Selexipag